Factors Related to Adherence to Statin Therapy
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
AbstractBackground:Retrospective database analyses have revealed that 50% of patients receiving statins discontinue therapy after one year of treatment. Typically, these data do not focus on patient-specific reasons for discontinuation.Objective:To examine the reasons that patients discontinue statins and compare the patient and clinical factors of those who do and do not discontinue therapy.Methods:All patients with a new statin prescription between January 1, 2004, and March 31, 2004, were identified through pharmacy claims. Patients who had discontinued and continued statin therapy were identified. Medical records were reviewed to determine whether there were documented reasons for statin discontinuation. Subsequently, telephone surveys addressing statin knowledge, relationships, communication with healthcare providers, and general health status were conducted.Results:At one year, 47.5% (n = 671) of patients had obtained fewer than 80% of the refills of their prescribed statin. We reviewed 435 medical records and conducted 255 patient surveys. A total of 29.9% of discontinuers had reasons documented in the medical record. Compared with continuers, fewer discontinuers had follow-up and/or laboratory visits with a provider within 6 months after the start of statin therapy. The surveys indicated that more continuers than discontinuers trusted their providers (p < 0.05) and felt that providers had adequate knowledge to answer their questions (p < 0.001). In contrast, more discontinuers felt the statin was of limited benefit/unsure of the benefit (p < 0.001) and believed that their providers were not interested in their input on their medical condition (p < 0.01).Conclusions:Utilizing pharmacy claims records alone to determine statin nonadherence may not only overestimate the percentage of patients who are nonadherent, but also prevent healthcare providers from understanding the reasons that patients discontinue or continue statin therapy. Statin adhorence is complex and affected by several factors. Interventions to improve adherence should focus on patient communications, education, and follow-up ResumenTrasfondo:Principalmente a base de un análisis retrospectivo en una base de datos; el 50% de los pacientes que están recibiendo estatinas descontinúan su tratamiento al año. Típicamente, estos datos no enfocaron las razones específicamente para la discontinuación.Objetivos:Examinar las razones por las cuales los pacientes descontinuaron las estatinas; como también, comparar el paciente y los factores clínicos de aquellos que descontinuaron y los que no descontinuaron las estatinas.Métodos:Todos los pacientes con una receta nueva entre 2004 enero–2004 marzo fueron identificados a través de reclamaciones en la farmacia. A su vez, se identificaron los pacientes que descontinuaron y los que continuaron el tratamiento. Los expedientes médicos fueron revisados para determinar si se documentaron las razones para la descontinuación de la estatina. Subsecuentemente, se condujo una encuesta por teléfono dirigida a determinar el conocimiento sobre estatinas, relaciones, comunicación con el proveedor médico, y el estado general de salud.Resultados:En un año, un 47.5% (n = 671) de los pacientes han obtenido menos del 80% de la estatinas prescritas. Se revisaron 435 expedientes médicos y 255 encuestas a pacientes fueron conducidas. Un total de 29.9% de los pacientes que descontinuaron la estatina tenían documentadas las razones en el expediente médico. Comparado con los pacientes que siguieron con el tratamiento, pocos de los pacientes que descontinuaron la estatina tuvieron un seguimiento y/o cita de laboratorio con su proveedor a los 6 meses subsiguientes al comienzo del tratamiento. Dentro de las encuestas, comparado con los pacientes que descontinuaron, hubieron más pacientes que siguieron en el tratamiento y confiaban en sus proveedores (p < 0.05) y sintieron que su proveedor teñía conocimiento adecuado al contestar sus preguntas (p < 0.001). Por otra parte, los pacientes que descontinuaron creian que la estatina era de beneficio limitado o inseguro del beneficio (p < 0.001) y sintieron que sus proveedores no estaban interesados en sus aportaciones en su condición médica (p < 0.01).Conclusiones:Utilizando solo los expedientes de reclamaciones de la farmacia para determinar la falta de adherencia podría no solamente sobrestimarse el por ciento de pacientes con no adherencia; sino también, impide a los proveedores de salud a comprender las razones por los cuales los pacientes descontinuaron o continuaron las terapias de estatina. El cumplimento al tratamiento de estatina es complejo y está afectado por varios factores. Las intervenciones para mejorar la adherencia deben estar enfocadas en la comunicación, educación, y seguimiento del paciente.Contexte:Selon les analyses rétrospectives de bases de données, 50% des patients recevant une statine cessent leur traitement après un an. De façon générale, ces données ne traiten
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., Wu, A. W., & PATIENT CARE COMMITTEE & ADHERENCE (2000) · AIDS Care · doi:10.1080/09540120050042891 · Cited by 1,428
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
Predictors of Adherence With Antihypertensive and Lipid-Lowering Therapy
Chapman, R. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.10.1147 · Cited by 506
Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
Benner, J. S., Tierce, J. C., Ballantyne, C. M., Prasad, C., Bullano, M. F., Willey, V. J., Erbey, J., & Sugano, D. S. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422003-00003 · Cited by 115
Cited by
Cooper, L. A., Roter, D. L., Carson, K. A., Beach, M. C., Sabin, J. A., Greenwald, A. G., & Inui, T. S. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300558 · Cited by 815
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
Boekholdt, S. M., Hovingh, G. K., Mora, S., Arsenault, B. J., Amarenco, P., Pedersen, T. R., LaRosa, J. C., Waters, D. D., DeMicco, D. A., Simes, R. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.615 · Cited by 581
Discontinuation of Statins in Routine Care Settings: A Cohort Study
Zhang, H., Plutzky, J., Skentzos, S., Morrison, F., Mar, P., Shubina, M., & Turchin, A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-7-201304020-00004 · Cited by 548
Prevalence of statin intolerance: a meta-analysis
Bytyçi, I., Penson, P. E., Mikhailidis, D. P., Wong, N. D., Hernandez, A. V., Sahebkar, A., Thompson, P. D., Mazidi, M., Rysz, J., Pella, D., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac015 · Cited by 481
Wadhera, R. K., Steen, D. L., Khan, I., Giugliano, R. P., & Foody, J. M. (2016) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.11.010 · Cited by 306
“Rates of nonadherence are high, thus it is possible that without lipid monitoring, nonadherence may be less frequently identified.(106) De-emphasis of achievement of specific LDL-C levels leaves it unclear whether physicians should consider the addition of other lipid-lowering treatments in patients with recalcitrantl…”
Background
Metadata
- Authors
- McGinnis, B., Olson, K. L., Magid, D., Bayliss, E., Korner, E. J., Brand, D. W., & Steiner, J. F.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2007-09-25
- Volume
- 41
- Issue
- 11
- Pages
- 1805-1811
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2121933788
- Cited by
- 121
- References
- 5
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Factors Related to Adherence to Statin Therapy. https://app.cochat.ai/papers/10.1345/aph.1k209
- The paper
- McGinnis, B., Olson, K. L., Magid, D., Bayliss, E., Korner, E. J., Brand, D. W., & Steiner, J. F. (2007). Factors Related to Adherence to Statin Therapy. Annals of Pharmacotherapy. https://doi.org/10.1345/aph.1k209
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.